Stock listing

NYSE:MKG Mallinckrodt Inc Stock

Follow Mallinckrodt Inc into a list and get an email when it puts out news.

Delisted NYSE:MKG no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NYSE:MKG
Asset type
Stock
Exchange
NYSE
Currency
USD

Mallinckrodt Inc on 6ix

Decks
16 decks · latest Nov 10, 2025

Where Mallinckrodt Inc is listed

ListingExchangeCountryCurrency
NYSE:MKG · This page · DelistedNYSEUnited StatesUSD
NYSE American:MNK · DelistedNYSE AmericanUnited StatesUSD
OTC:MNKTQ · DelistedOTCUnited StatesUSD

Decks

DeckKindSlidesDate
Q3 2025 Earnings PresentationEarnings17 slidesNov 10, 2025
Debt Investor Presentation (October 2025)Debt investors25 slidesOct 6, 2025
Merger or Acquisition (August 2025)Merger or acquisition87 slidesAug 1, 2025
Debt Investor Presentation (August 2025)Debt investors57 slidesAug 1, 2025
Merger or Acquisition (March 2025)Merger or acquisition15 slidesMar 13, 2025
Merger or Acquisition (March 2025)Merger or acquisition16 slidesMar 13, 2025
Debt Investor Presentation (August 2023)Debt investors14 slidesAug 23, 2023
43rd Annual TD Cowen Health Care Conference (March 2023)Conference13 slidesMar 7, 2023
Debt Investor Presentation (April 2022)Debt investors46 slidesApr 14, 2022
Corporate Update (March 2021)Corporate update20 slidesMar 10, 2021
All 16 decks
DeckKindSlidesDate
Presentation (October 2020)43 slidesOct 13, 2020
Merger or Acquisition (December 2018)Merger or acquisition15 slidesDec 6, 2018
Merger or Acquisition (December 2017)Merger or acquisition18 slidesDec 26, 2017
Merger or Acquisition (August 2015)Merger or acquisition11 slidesAug 11, 2015
Merger or Acquisition (March 2015)Merger or acquisition8 slidesMar 5, 2015
Merger or Acquisition (February 2014)Merger or acquisition12 slidesFeb 11, 2014

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Paul M. Bisaro
Other companies: Myriad Genetics, Inc. (Director · Since at least Oct 31, 2022); Zoetis Inc. (Chairman of the Board · Since at least May 1, 2015); TherapeuticsMD, Inc. (Director · Mar 20, 2020 – Sep 29, 2022 · Past); Amneal Pharmaceuticals, Inc. (Executive Chairman, Director · May 4, 2018 – May 7, 2019 · Past); Impax Laboratories Inc (President and CEO, Director · Mar 27, 2017 – May 4, 2018 · Past); Zimmer Biomet Holdings, Inc. (Director · Dec 12, 2013 – Mar 31, 2017 · Past)
Director · Since at least Jun 16, 2022
Katina Dorton
Other companies: Prelude Therapeutics Incorporated (Director · Since at least Oct 17, 2025); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); Fulcrum Therapeutics, Inc. (Board Member · Since at least Jun 9, 2021); US Ecology Inc (Director · May 26, 2021 – May 2, 2022 · Past); Pandion Therapeutics Inc (Director · Dec 2, 2020 – Apr 1, 2021 · Past)
Director · Since at least Feb 2, 2024
Bryan M Reasons
Other companies: Amneal Pharmaceuticals, Inc. (CFO · May 4, 2018 – Aug 21, 2018 · Past); Aclaris Therapeutics, Inc. (Director · Apr 20, 2018 – Jun 1, 2024 · Past); Recro Pharma Inc (Director · Mar 3, 2017 – Apr 8, 2024 · Past); Impax Laboratories Inc (Chief Financial Officer · Apr 13, 2013 – May 4, 2018 · Past)
EVP & CFO · Since at least Mar 18, 2019
Carlos Paya
Other companies: Collegium Pharmaceutical, Inc. (Director · Since at least May 15, 2025); Vaxcyte, Inc. (President, Immune Design Corp Chairman, Vaxcyte · Since at least Oct 27, 2021); Standard BioTools Inc. (Director · Mar 23, 2017 – Jun 14, 2023 · Past); Immune Design Corp (President and CEO, Director · Oct 30, 2015 – Apr 2, 2019 · Past)
Director · May 22, 2019 – Jun 16, 2022 · Past
Karen Ling
Other companies: Bausch + Lomb Corporation (Director · Since at least Feb 27, 2024); iRhythm Holdings, Inc. (Director · Since at least Nov 1, 2021); TherapeuticsMD, Inc. (Director · Apr 16, 2020 – Sep 29, 2022 · Past); American International Group, Inc. New (EVP and Chief HR Officer · Jul 29, 2019 – Mar 30, 2021 · Past)
Director · Aug 12, 2022 – Nov 14, 2023 · Past
Daniel Tassé
Other companies: DBV Technologies SA (Chief Executive Officer · Since at least Jan 1, 2021); Regenxbio Inc. (Independent Board Member · Since at least Aug 15, 2016); Bellerophon Therapeutics Inc (Director · Feb 13, 2015 – Jun 21, 2018 · Past)
Interim Pres-Hospital Business · May 1, 2015 – May 1, 2015 · Past
Diane H Gulyas
Other companies: Ingevity Corporation (Director · Since at least Feb 22, 2019); Expeditors International of Washington, Inc. (Director · Since at least May 20, 2016); W. R. Grace & Co (Director · May 5, 2016 – Sep 22, 2021 · Past)
Director · Jul 21, 2016 – Mar 1, 2018 · Past
J Martin Carroll
Other companies: Esperion Therapeutics, Inc. (Director · Since at least Jun 1, 2022); TherapeuticsMD, Inc. (Director · Jul 1, 2021 – Aug 10, 2021 · Past); Catalent Inc (Director · Oct 29, 2020 – Dec 18, 2024 · Past)
Director · Mar 12, 2021 – Jun 16, 2022 · Past
Paul Carter
Other companies: Immatics N.V. (Non-Executive Director · Since at least Mar 18, 2026); Alder BioPharmaceuticals Inc (Director · Sep 28, 2015 – Oct 22, 2019 · Past); Gilead Sciences, Inc. (EVP Commercial Ops · Jul 1, 2015 – Aug 1, 2016 · Past)
Director · May 16, 2018 – Jun 16, 2022 · Past
Joann A Reed
Other companies: American Tower Corporation (REIT) (Director · Mar 10, 2017 – Mar 10, 2025 · Past); Waters Corporation (Director · Jan 4, 2016 – Mar 5, 2021 · Past)
Director · Jul 21, 2016 – Jun 16, 2022 · Past
All 28 people
PersonSeat
Matthew K Harbaugh
Other companies: Qnity Electronics, Inc. (Chief Financial Officer · Since at least Sep 30, 2025); NuVasive Inc (EVP and CFO · Jan 1, 2020 – Sep 1, 2023 · Past)
EVP & President, Spec Gen · Jan 2, 2018 – Apr 2, 2019 · Past
Steven J Romano
Other companies: Silence Therapeutics PLC (EVP and Chief R&D Officer · Since at least Jan 2, 2025); Dianthus Therapeutics, Inc. (Director · Since at least Sep 16, 2024)
EVP & Chief Sci. Ofcr · Jun 16, 2022 – Jun 16, 2022 · Past
Abbas Hussain
Other companies: Moderna, Inc. (Director · Since at least Oct 2, 2024)
Director · Since at least Feb 2, 2024
David R Carlucci
Other companies: Mastercard Incorporated (Director · Jun 11, 2019 – Jun 25, 2019 · Past)
Director · May 15, 2019 – Jun 16, 2022 · Past
Mark Trudeau
Other companies: TE Connectivity plc (Board Member · Since at least Nov 9, 2020)
President and CEO, Director · Nov 12, 2020 – Jun 16, 2022 · Past
Ronald K Lloyd
Other companies: Elutia, Inc. (PRESIDENT AND CEO, Director · Oct 7, 2020 – Mar 8, 2022 · Past)
Exec. VP & Pres, Hospital · Jan 4, 2016 – Apr 2, 2018 · Past
Susan Michele Silbermann
Other companies: Hillevax Inc (Director · Apr 28, 2022 – Aug 19, 2022 · Past)
Director · Oct 5, 2022 – Nov 14, 2023 · Past
Woodrow A Myers Jr
Other companies: Personalis, Inc. (Director · Since at least Mar 6, 2021)
Director · Jun 16, 2022 – Nov 14, 2023 · Past
Frank B RacitiController & CAO · Since at least Aug 19, 2025
Henriette NielsenEVP & Chief Transformation OFC · Since at least Aug 17, 2022
Hugh M O'NeillSee Remarks · May 10, 2016 – Jun 16, 2022 · Past
Hugh Paul ONeillEVP, Chief Operations Officer · Since at least Feb 28, 2024
Ian J WatkinsSee Remarks · Nov 11, 2020 – Jun 16, 2022 · Past
Kathy A SchaeferSr. VP Fin & Corp. Controller · Jun 28, 2013 – Apr 1, 2021 · Past
Mark T BradleyEVP, Chief Integration Officer · Since at least Jul 31, 2025
Scott HirschDirector · Since at least Jul 31, 2025
Tracy BassoEVP & CHRO · Since at least Jul 31, 2025
Wesley WheelerDirector · Since at least Jul 31, 2025

Open People

Log in to ask 6ix AI your own questions about Mallinckrodt Inc.